Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells

References

• AllenTMCullisPRDrug delivery systems: Entering the mainstreamScience200430356651818182215031496
   PubMed Web of Science ®Google Scholar
• LangerRTirrellDADesigning materials for biology and medicineNature2004428698248749215057821
   PubMed Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Del Rev2002545631651
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Del Rev2004561116491659
   PubMed Web of Science ®Google Scholar
• DavisMEChenZShinDMNanoparticle therapeutics: An emerging treatment modality for cancerNat Rev Drug Disc200879771782
   PubMed Web of Science ®Google Scholar
• RiehemannKSchneiderSWLugerTANanomedicine – Challenge and perspectivesAngew Chem Int Ed2009485872897
   PubMed Web of Science ®Google Scholar
• MoorthiCManavalanRKathiresanKNanotherapeutics to overcome conventional cancer chemotherapy limitationsJ Pharm Pharm Sci2011141677721501554
   PubMed Web of Science ®Google Scholar
• Vivero-EscotoJLSlowingIITrewynBGMesoporous silica nanoparticles for intracellular controlled drug deliverySmall20106181952196720690133
   PubMed Web of Science ®Google Scholar
• SlowingIIVivero-EscotoJLWuC-WMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Del Rev2008601112781288
   PubMed Web of Science ®Google Scholar
• LiuJQiaoSZHuQHMagnetic nanocomposites with mesoporous structures: synthesis and applicationsSmall20117442544321246712
   PubMed Web of Science ®Google Scholar
• Vallet-RegíMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed2007464075487558
   PubMed Web of Science ®Google Scholar
• RosenholmJMSahlgrenCLindénMTowards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities and challengesNanoscale20102101870188320730166
   PubMed Web of Science ®Google Scholar
• HeQShiJZhuMThe three-stage in vitro degradation behavior of mesoporous silica in simulated body fluidMicroporous Mesoporous Mater20101311–3314320
   Web of Science ®Google Scholar
• LuJLiongMLiZBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animalsSmall20106161794180520623530
   PubMed Web of Science ®Google Scholar
• LuoZCaiKHuYMesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug deliveryAngew Chem Int Ed2011503640643
   PubMed Web of Science ®Google Scholar
• BernardosAMondragonLAznarEEnzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with “saccharides”Acs Nano20104116353636820958020
   PubMed Web of Science ®Google Scholar
• BotellaPGaoFCormaAMonodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNAJ Phys Chem B200911361796180419152258
   PubMed Web of Science ®Google Scholar
• LuJLiongMZinkJIMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall2007381341134617566138
   PubMed Web of Science ®Google Scholar
• LuJLiongMShermanSMesoporous silica nanoparticles for cancer therapy: Energy-dependent cellular uptake and delivery of paclitaxel to cancer cellsNanobiotechnology200732899519936038
   PubMedGoogle Scholar
• HomCLuJLiongMMesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cellsSmall20106111185119020461725
   PubMed Web of Science ®Google Scholar
• LiXXieQRZhangJThe packaging of siRNA within the mesoporous structure of silica nanoparticlesBiomaterials201132359546955621906804
   PubMed Web of Science ®Google Scholar
• SlowingIITrewynBGLinVSYMesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteinsJ Am Chem Soc2007129288845884917589996
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• JiaJZhuFMaXMechanisms of drug combinations: interaction and network perspectivesNat Rev Drug Discov20098211112819180105
   PubMed Web of Science ®Google Scholar
• GaspariniGLongoRFanelliMCombination of antiangiogenic therapy with other anticancer therapies: Results, challenges, and open questionsJ Clin Oncol20052361295131115718328
   PubMed Web of Science ®Google Scholar
• FitzgeraldJBSchoeberlBNielsenUBSystems biology and combination therapy in the quest for clinical efficacyNat Chem Biol20062945846616921358
   PubMed Web of Science ®Google Scholar
• OliveKPJacobetzMADavidsonCJInhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerScience200932459331457146119460966
   PubMed Web of Science ®Google Scholar
• HainsworthJDSpigelDRBurrisHAPhase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinomaJ Clin Oncol201028132131213620368560
   PubMed Web of Science ®Google Scholar
• MengHLiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsSmall20095232673267719780069
   PubMed Web of Science ®Google Scholar
• WangBRosanoJMCheheltaniReTowards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancerExp Opin Drug Deliv201071011591173
   PubMed Web of Science ®Google Scholar
• AshleyCECarnesECPhillipsGKThe targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNat Mater201110538939721499315
   PubMed Web of Science ®Google Scholar
• HeQGaoYZhangLA pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistanceBiomaterials201132307711772021816467
   PubMed Web of Science ®Google Scholar
• JingouJShileiHWeiqiLPreparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release studyColloids Surf B Biointerfaces201183110310721112190
   PubMed Web of Science ®Google Scholar
• LiXZhangJGuHAdsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticlesLangmuir201127106099610621488610
   PubMed Web of Science ®Google Scholar
• ZhangJLiXRosenholmJMSynthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticlesJ Colloid Interface Sci20113611162421689824
   PubMed Web of Science ®Google Scholar
• KimJKimHSLeeNMultifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug deliveryAngew Chem20081204485668569
   Google Scholar
• BrunauerSEmmettPHTellerEAdsorption of gases in multimolecular layersJ Am Chem Soc1938602309319
   Google Scholar
• RavikovitchPIWeiDChuehWTEvaluation of pore structure parameters of MCM-41 catalyst supports and catalysts by means of nitrogen and argon adsorptionJ Phys Chem B19971011936713679
   Web of Science ®Google Scholar
• IyerAKKhaledGFangJExploiting the enhanced permeability and retention effect for tumor targetingDrug Disc Today20061117–18812818
   PubMed Web of Science ®Google Scholar
• RizellMAnderssonMCahlinCEffects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancerInt J Clin Oncol2008131667018307022
   PubMed Web of Science ®Google Scholar
• de MacedoJLBragaPRSCostaAALiquid phase calorimetric-adsorption analysis of Si-MCM-41: Evidence of strong hydrogen-bonding sitesMicroporous Mesoporous Mater20111391–37480
   Web of Science ®Google Scholar
• LuhmerMd’EspinoseJBHommelHHigh-resolution Si-29 solid-state NMR study of silicon functionality distribution on the surface of silicasMagn Reson Imaging1996147–89119138970108
   PubMed Web of Science ®Google Scholar
• ChangBGuoJLiuCSurface functionalization of magnetic mesoporous silica nanoparticles for controlled drug releaseJ Mater Chem2010204499419947
   Web of Science ®Google Scholar
• KorsmeyerRWGurnyRDoelkerEMechanisms of solute release from porous hydrophilic polymersInt J Pharm19831512535
   Web of Science ®Google Scholar
• LiongMLuJKovochichMMultifunctional inorganic nanoparticles for imaging, targeting, and drug deliveryACS Nano20082588989619206485
   PubMed Web of Science ®Google Scholar
• SeftelEMPopoviciRFMihaiGDControlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drugJ Pharm Sci2011100270471420740675
   PubMed Web of Science ®Google Scholar
• AnderssonJRosenholmJArevaSInfluences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matricesChem Mater2004162141604167
   Web of Science ®Google Scholar
• XuYTangQWuDStudies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug deliveryJ Controlled Release200611414146
   Web of Science ®Google Scholar
• CapranicoGKohnKWPommierYLocal sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicinNucleic Acids Res19901822661166192174543
   PubMed Web of Science ®Google Scholar
• HuangDMHongYKoBSHighly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell trackingFASEB J2005192014201616230334
   PubMed Web of Science ®Google Scholar
• JinCLiHHeYCombination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivoJ Cancer Res Clin Oncol2010136226727419693537
   PubMed Web of Science ®Google Scholar
• Di PasquaAJSharmaKKShiYLCytotoxicity of mesoporous silica nanomaterialsJ Inorg Biochem200810271416142318279965
   PubMed Web of Science ®Google Scholar
• TrailPAWillnerDBianchiABEnhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicinClin Cancer Res19995113632363810589780
   PubMed Web of Science ®Google Scholar